Stock Information
United Therapeutics Corp (UTHR)
Ticker Symbol: UTHR
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $21,696.22 mil
Piotroski score: 5
PE Ratio: 16.9663
EPS (TTM): 27.9001
Revenue (TTM): $67.29 M
Dividend Yield: N/A%
ROE: 19.3%
Latest News
-
United Therapeutics Corporation to Present at the Leerink Global Healthcare Conference
Tue, Mar 3, 2026 12:00 PM
-
United Therapeutics Corporation (UTHR) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Mon, Mar 2, 2026 4:27 PM
-
United Therapeutics Corporation (UTHR) Discusses Phase III ADVANCE OUTCOMES Clinical Trial Results in Pulmonary Hypertension Transcript
Mon, Mar 2, 2026 4:07 PM
-
United Therapeutics Corporation (UTHR) Discusses Phase III ADVANCE OUTCOMES Clinical Trial Results in Pulmonary Hypertension - Slideshow
Mon, Mar 2, 2026 3:58 PM
-
United Therapeutics' Trial Shows 55% Drop in Lung Disease Worsening
Mon, Mar 2, 2026 11:32 AM
-
United Therapeutics Corporation Announces Ralinepag Achieved 55% Reduction in Risk of Clinical Worsening in Pivotal Pulmonary Arterial Hypertension Study, Delivering Exceptional, Highly Statistically Significant Efficacy
Mon, Mar 2, 2026 11:30 AM
-
United Therapeutics Says Phase 3 ADVANCE OUTCOMES Study Of Ralinepag Met Primary Endpoint And Several Important Secondary Endpoints, In Predominantly Pre-Treated Patients With PAH
Mon, Mar 2, 2026 7:34 AM
-
H.C. Wainwright Raises United Therapeutics (UTHR) Target to $600
Sun, Mar 1, 2026 3:04 PM
-
Assessing United Therapeutics (UTHR) Valuation After Strong Earnings And Pipeline Updates
Sun, Mar 1, 2026 1:12 AM
-
2 Cash-Producing Stocks to Keep an Eye On and 1 That Underwhelm
Fri, Feb 27, 2026 3:36 PM
Key Financials
Financial data not available
